Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fiona McKay

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 27, 2025
Toward a global research agenda for preventing multiple sclerosisRuth Ann Marrie, Ruth Dobson, Sergio E Baranzini, et al.
BMJ (Clinical Research Ed.)|July 6, 2016
Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down's syndrome into NHS maternity care: prospective cohort study in eight diverse maternity unitsLyn S Chitty, David Wright, Melissa Hill, et al.
BMC Pregnancy and Childbirth|July 17, 2014
Evaluation of non-invasive prenatal testing (NIPT) for aneuploidy in an NHS setting: a reliable accurate prenatal non-invasive diagnosis (RAPID) protocolMelissa Hill, David Wright, Rebecca Daley, et al.
ACS Chemical Neuroscience|August 4, 2021
<i>Ascaris suum</i> Informs Extrasynaptic Volume Transmission in NematodesLouise E Atkinson, Yang Liu, Fiona McKay, et al.
Bioorganic & Medicinal Chemistry Letters|March 5, 2008
Potent achiral agonists of the growth hormone secretagogue (ghrelin) receptor. Part 2: Lead optimisationJason Witherington, Lee Abberley, Michael A Briggs, et al.
Bioorganic & Medicinal Chemistry Letters|November 5, 2008
Identification of small molecule agonists of the motilin receptorTom D Heightman, Elizabeth Conway, David F Corbett, et al.
Bioorganic & Medicinal Chemistry Letters|January 9, 2009
Aryl sulphonyl amides as potent agonists of the growth hormone secretagogue (ghrelin) receptorJason Witherington, Lee Abberley, Benjamin R Bellenie, et al.
Bioorganic & Medicinal Chemistry Letters|October 19, 2007
Potent achiral agonists of the ghrelin (growth hormone secretagogue) receptor. Part I: Lead identificationTom D Heightman, Jackie S Scott, Mark Longley, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2009
The discovery and optimisation of benzazepine sulfonamide and sulfones as potent agonists of the motilin receptorJames M Bailey, Jackie S Scott, Jonathan B Basilla, et al.
BMJ Neurology Open|December 26, 2025
Study protocol for a multicentre, randomised, double-blinded, placebo-controlled, multi-arm, multi-stage, trial of SpironolacTone and famciclOovir in the treatment of Progressive Multiple Sclerosis to prevent disability progression: the STOP-MS trialKayla Ward, Vivien Li, Sudarshini Ramanathan, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 27, 2025
Toward a global research agenda for preventing multiple sclerosisRuth Ann Marrie, Ruth Dobson, Sergio E Baranzini, et al.
BMJ (Clinical Research Ed.)|July 6, 2016
Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down's syndrome into NHS maternity care: prospective cohort study in eight diverse maternity unitsLyn S Chitty, David Wright, Melissa Hill, et al.
BMC Pregnancy and Childbirth|July 17, 2014
Evaluation of non-invasive prenatal testing (NIPT) for aneuploidy in an NHS setting: a reliable accurate prenatal non-invasive diagnosis (RAPID) protocolMelissa Hill, David Wright, Rebecca Daley, et al.
ACS Chemical Neuroscience|August 4, 2021
<i>Ascaris suum</i> Informs Extrasynaptic Volume Transmission in NematodesLouise E Atkinson, Yang Liu, Fiona McKay, et al.
Bioorganic & Medicinal Chemistry Letters|March 5, 2008
Potent achiral agonists of the growth hormone secretagogue (ghrelin) receptor. Part 2: Lead optimisationJason Witherington, Lee Abberley, Michael A Briggs, et al.
Bioorganic & Medicinal Chemistry Letters|November 5, 2008
Identification of small molecule agonists of the motilin receptorTom D Heightman, Elizabeth Conway, David F Corbett, et al.
Bioorganic & Medicinal Chemistry Letters|January 9, 2009
Aryl sulphonyl amides as potent agonists of the growth hormone secretagogue (ghrelin) receptorJason Witherington, Lee Abberley, Benjamin R Bellenie, et al.
Bioorganic & Medicinal Chemistry Letters|October 19, 2007
Potent achiral agonists of the ghrelin (growth hormone secretagogue) receptor. Part I: Lead identificationTom D Heightman, Jackie S Scott, Mark Longley, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2009
The discovery and optimisation of benzazepine sulfonamide and sulfones as potent agonists of the motilin receptorJames M Bailey, Jackie S Scott, Jonathan B Basilla, et al.
BMJ Neurology Open|December 26, 2025
Study protocol for a multicentre, randomised, double-blinded, placebo-controlled, multi-arm, multi-stage, trial of SpironolacTone and famciclOovir in the treatment of Progressive Multiple Sclerosis to prevent disability progression: the STOP-MS trialKayla Ward, Vivien Li, Sudarshini Ramanathan, et al.
Pageof 4